Interactions between cationic liposomes and drugs or biomolecules

21Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Multiple uses for synthetic cationic liposome, composed of dioctadecyldimethylammonium bromide (DODAB) bilayer vesicles are presented. Drugs or biomolecules can be solubilized or incorporated in the cationic bilayers. The cationic liposomes themselves can act as antimicrobial agents causing death of bacteria and fungi at concentrations that barely affect mammalian cells in culture. Silica particles or polystyrene microspheres can be functionalized by coverage with DODAB bilayers or phospholipid monolayers. Negatively charged antigenic proteins can be carried by the cationic liposomes which generate a remarkable immunoadjuvant action. Nucleotides or DNA can be physically adsorbed to the cationic liposomes to be transferred to mammalian cells for gene therapy. An overview of the interactions between DODAB vesicles and some biomolecules or drugs clearly points out their versatility for useful applications in a near future.

Cite

CITATION STYLE

APA

Carmona-Ribeiro, A. M. (2000). Interactions between cationic liposomes and drugs or biomolecules. Anais Da Academia Brasileira de Ciencias, 72(1), 39–43. https://doi.org/10.1590/s0001-37652000000100005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free